Immediate Suboptimal Result of Mitral Valve Repair: Late Implications in a Matched Cohort Study
NCT ID: NCT05836480
Last Updated: 2023-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
141 participants
OBSERVATIONAL
2019-10-05
2019-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Mitral valve repair surgery represents the gold standard for the treatment of severe degenerative mitral regurgitation. The expected optimal result would be the absence of residual post-procedural mitral regurgitation, even if it is not uncommon to obtain a valve with residual regurgitation of a mild degree. In some cases, for various reasons (technical difficulties, long aortic clamping time, advanced age, high pre-operative surgical risk), a suboptimal result is accepted, i.e. a post-procedural residual mitral regurgitation of even a moderate degree ( 0, 1+, or 2+/4+).
The aim of the present study is to evaluate the late clinical and echocardiographic implications of suboptimal mitral valve repair with a paired-data cohort study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Are the Results of Minimally Invasive Mitral Valve Repair Still Satisfactory When Looked at Very Long-term?
NCT05836558
Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
NCT05836532
Fate of Moderate Secondary Mitral Regurgitation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Regurgitation
NCT05774808
LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery
NCT05774795
Is Mitral Annuloplasty an Effective Treatment for Severe Atrial Functional MR?
NCT05836376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suboptimal repair
Patients discharged with a residual mitral regurgitation of at least moderate (2+)degree
mitral valve repair
conservative surgery to treat mitral regurgitation. A mitral valve plasty is performed according to the most appropriate technique
Optimal repair
Patients discharged with a residual mitral regurgitation of mild (1+) or less degree (trace or 0)
mitral valve repair
conservative surgery to treat mitral regurgitation. A mitral valve plasty is performed according to the most appropriate technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mitral valve repair
conservative surgery to treat mitral regurgitation. A mitral valve plasty is performed according to the most appropriate technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* presence of severe degenerative mitral regurgitation treated by mitral valve repair between 2006 and 2013;
* presence of moderate residual mitral regurgitation at discharge.
* Control group:
* presence of severe degenerative mitral regurgitation treated by mitral valve repair between 2006 and 2013;
* presence of residual mitral regurgitation of at least mild grade at discharge.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Michele De Bonis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michele De Bonis
Chief of Cardiac Surgery of Advance and Research Therapies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Ospedale San Raffaele
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUB-MVR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.